PATHWAY CAPITAL MANAGEMENT, LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001037353

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHealth TiltHigh Turnover how tags are computed

Q3 2025 · 7 positions · Total reported value $20.34M · Top-10 concentration 100.0% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 100.0% · 3 new · 0 cut · 4 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

In its Q3 2025 13F filing, PATHWAY CAPITAL MANAGEMENT, LP disclosed 7 equity positions with a combined reported value of $20.34M. The filing implies a focused portfolio: its ten largest positions account for 100.0% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2025 were HIMS ($6.77M), ACLX ($4.19M), GDRX ($4.17M). By sector, the heaviest allocations are Health Care 49.2%, Technology 20.5%. Versus the prior quarter, allocation shifted toward Health Care (+49.2pp), Other (+20.9pp) and away from Technology (-78.5pp).

Versus the prior quarter, PATHWAY CAPITAL MANAGEMENT, LP opened 3 new positions, trimmed 0 and fully exited 4, a turnover rate of 100.0% of positions. The portfolio's overlap with the prior quarter was 21% of names.

The largest new positions opened in Q3 2025 were HIMS ($6.77M), ACLX ($4.19M), CRSP ($3.24M).

Of the 4 positions fully exited versus the prior quarter, the largest were RBRK ($57.62M), TOST ($10.92M), TTAN ($6.86M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2025)

  • HIMS HIMS & HERS HEALTH INC · $6.77M
  • ACLX ARCELLX INC · $4.19M
  • CRSP CRISPR THERAPEUTICS AG · $3.24M
  • PDD PDD HOLDINGS INC · $951.23K

Fully Exited (vs previous quarter)

  • RBRK RUBRIK INC. · prev qtr: $57.62M
  • TOST TOAST INC · prev qtr: $10.92M
  • TTAN SERVICETITAN INC · prev qtr: $6.86M
  • BRZE BRAZE INC · prev qtr: $4.81M
  • CXM SPRINKLR INC · prev qtr: $4.62M
  • AMPL AMPLITUDE INC · prev qtr: $2.68M
  • ABNB AIRBNB INC · prev qtr: $299.88K

Insider Transactions (Form 4)

Latest PATHWAY CAPITAL MANAGEMENT, LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Pathway Capital Management, based in Irvine, CA, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 4 positions worth $23.95M in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: IRVINE, CA, United States
  • SEC registration: 801-54251 (status: Approved), registered 1997-04-11
  • Regulatory AUM (Form ADV): $74.17B as of 2026-06-30
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 103 private funds
  • Website: pathwaycapital.com

Portfolio Structure

  • 4 positions · $23.95M reported value (Q2 2026)
  • Top 10 holdings = 100.0% of reported value
  • Largest position: RBRK (RUBRIK INC CLASS A) at 53.6%
  • Average position size: $5.99M

Sector Tilt

  • Information Technology 66.3%
  • Financials 33.7%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 4 new, 2 exited

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 49.2%
Technology 20.5%
Financials 4.6%
Other 21.0%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 119.28K $6.77M 33.26%
33.26%
New
2 51.05K $4.19M 20.60%
20.60%
New
3 986.16K $4.17M 20.51%
20.51%
Add
4 50.05K $3.24M 15.95%
15.95%
New
5 7.20K $951.23K 4.68%
4.68%
New
6 59.01K $944.75K 4.64%
4.64%
Add
7 11.20K $74.71K 0.37%
0.37%
Hold

FAQ

What did PATHWAY CAPITAL MANAGEMENT, LP buy in 2025-Q3?

In its 2025-Q3 13F filing, PATHWAY CAPITAL MANAGEMENT, LP reported 7 equity positions worth $20.34M in aggregate; its largest disclosed positions were HIMS ($6.77M), ACLX ($4.19M), GDRX ($4.17M).

How large is PATHWAY CAPITAL MANAGEMENT, LP's portfolio?

PATHWAY CAPITAL MANAGEMENT, LP reported $20.34M of long equity holdings across 7 positions as of 2025-Q3. Top-10 holdings account for 100.0% of reported value.

What is PATHWAY CAPITAL MANAGEMENT, LP's investment style?

HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/pathway-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →